‘When do I sell my stocks?’ Ignore the noise and focus on these things.

A 76-year-old retired professor asked when to sell stocks after investing for 47 years in companies he viewed as financial bulwarks with steady, rising dividends. He said his portfolio had grown to about $250,000, including more than 1,000 Bank of America shares and 500 Citi shares; the article excerpt does not provide the adviser’s strategy or a recommendation.

Analysis

There is no company-specific catalyst here; the signal is about decision discipline, not a new fundamental view on Bank of America (BAC) or Citigroup (C). The relevant portfolio risk is that two separate holdings can still be one macro bet: large-bank stocks may respond together to changes in the yield curve, credit losses, funding costs, regulation, and capital-return constraints. Reinvested dividends can quietly deepen that exposure. The article does not give position values, cost bases, or the rest of the portfolio, so concentration cannot be quantified.

For BAC and C, a price decline alone is not evidence that the business outlook has deteriorated. Over the next 1–3 months, compare earnings and guidance on net interest income, deposit costs, credit provisions, and capital returns with the investor’s original thesis; over 6–18 months, watch whether credit quality and regulatory capital requirements alter sustainable returns. A change in those measures is more decision-relevant than short-term market noise. No trade is supported by this article alone.

Key Decisions for Investors

• No event-driven position in BAC or C: the article adds no fresh information about either company’s earnings, valuation, or capital returns.
• Review the portfolio’s combined financial-sector exposure, not just each bank holding in isolation. If that exposure exceeds the investor’s intended risk budget, consider staged rebalancing into a diversified alternative rather than making a price-triggered all-at-once sale.
• Set a thesis-based review trigger for each holding: reassess if guidance or reported results show sustained deterioration in net interest income, deposit costs, credit provisions, or capital-return capacity. These are monitoring criteria, not claims that deterioration has occurred.
• Falsification check: if price weakness is accompanied by stable or improving operating metrics and capital-return capacity, a sell signal based on price alone is weakened; if operating metrics or guidance materially deteriorate, the original hold thesis needs review.